
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Neuropharm | LSE:NPH | London | Ordinary Share | GB00B1NPJJ01 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.50 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMZZZ TIDMNPH FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing Mr Trevor & Mrs Jeanette Lambarth (Note 1) Company dealt in Neuropharm Group Plc Class of relevant security 10p Ordinary to which the dealings being disclosed relate (Note 2) Date of dealing 23 March 2010 (Mr & Mrs Lambarth dealt on previous dates during the Offer period as set out in this Form) 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 770,000 2.44 (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 770,000 2.44 (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number Number (%) (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Purchase 30,000 0.0983 Mr & Mrs Lambarth have also carried out the following dealings which have not previously been disclosed : Date Purchase / Sale Number of Price per Unit Securities 3 November 2009 Purchase 20,000 0.1810 3 November 2009 Purchase 25,000 0.1988 17 December 2009 Purchase 20,000 0.1350 17 December 2009 Purchase 55,000 0.1250 4 January 2010 Purchase 30,000 0.1275 4 January 2010 Purchase 20,000 0.1260 4 January 2010 Purchase 30,000 0.1150 11 February 2010 Purchase 20,000 0.0900 12 February 2010 Purchase 40,000 0.0800 12 March 2010 Purchase 20,000 0.1200 12 March 2010 Purchase 30,000 0.1135 22 March 2010 Purchase 30,000 0.1085 (b) Derivatives transactions (other than options) Product name, Long/short Number of securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, Expiry Option e.g. call selling, securities price e.g. date money option purchasing, to which the American, paid/received varying option European per unit etc. relates etc. (Note 5) (Note 7) (ii) Exercising Product name, e.g. call Number of securities Exercise price per unit option (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (if (Note 8) applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. NONE Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 25 March 2010 Contact name Mr T Lambarth Telephone number 01420 82707 If a connected EFM, name of N /A offeree/offeror with which connected If a connected EFM, state nature of N/A connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk
1 Year Neuropharm Chart |
1 Month Neuropharm Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions